Bleakley Financial Group, LLC Alaunos Therapeutics, Inc. Transaction History

Bleakley Financial Group, LLC

  • $3.28 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$0.12 - $0.5 $32 - $134
-269 Reduced 1.85%
14,250 $1.88 Million
Q2 2023

Aug 14, 2023
BUY
$0.43 - $0.65 $401 - $606
933 Added 6.87%
14,519 $7.41 Million
Q1 2023

May 12, 2023
SELL
$0.46 - $0.81 $544 - $958
-1,183 Reduced 8.01%
13,586 $8.56 Million
Q4 2022

Feb 07, 2023
BUY
$0.5 - $261.0 $7,384 - $3.85 Million
14,769 New
14,769 $9.59 Million

Others Institutions Holding TCRT

# of Institutions
5
Shares Held
92.6K
Call Options Held
0
Put Options Held
0
View Full List

About Alaunos Therapeutics, Inc.

TCRT Quotes by TradingView
  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $424M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Bleakley Financial Group, LLC Portfolio

Follow Bleakley Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bleakley Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bleakley Financial Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email